March 2013

Life Science Industry Outlook

Drug Approvals hit highest figure since 1996

The FDA approved 39 new drugs during 2012, up from 31 in 2011 and 21 approved in 2010. This is the highest amount since 1996 when the FDA approved 53 new drugs. Analysts attribute this increase to key factors:  1) FDA's efforts to efficiently move new molecular entities (NME's) through the approval process and fast track some key drugs, and 2) industry's better understanding of how to navigate the regulatory pathway.